EV/EBITDA:
-9.53-0.08(-0.85%)Summary
- As of today, TNGX EV/EBITDA is -9.53, with a fall of -0.08 (-0.85%) during the most recent trading session on December 19, 2025.
- Over the past year, TNGX EV/EBITDA has dropped by -8.97 (-1601.79%).
- TNGX EV/EBITDA is now -703.16% below its all-time high of 1.58.
Performance
TNGX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TNGX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -0.8% | +0.8% | +0.7% |
| 1M1 Month | +16.5% | -16.5% | -15.1% |
| 3M3 Months | -116.1% | +50.6% | +14.4% |
| 6M6 Months | -261.0% | +171.2% | +65.1% |
| YTDYTD | -1121.8% | +822.5% | +175.7% |
| 1Y1 Year | -1601.8% | +1229.5% | +174.8% |
| 5Y5 Years | -7.8% | +338.2% | -22.9% |
TNGX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -9.45 | -3.1% | -12.51 | +23.8% |
| 3M | 3-Month | -4.29 | -122.1% | -12.51 | +23.8% |
| 6M | 6-Month | -2.46 | -302.1% | -12.51 | +23.8% |
| 1Y | 1-Year | 0.44 | -2265.9% | -12.51 | +23.8% |
| 3Y | 3-Year | 0.51 | -1968.6% | -12.51 | +23.8% |
| 5Y | 5-Year | 1.58 | -703.2% | -29.78 | +68.0% |
| All-Time | All-Time | 1.58 | -703.2% | -451K | +100.0% |
TNGX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -9.53(-1121.8%) |
| 2024 | -0.78(+88.0%) |
| 2023 | -6.48(-121.2%) |
| Date | Value |
|---|---|
| 2022 | -2.93(+65.1%) |
| 2021 | -8.39(-374.0%) |
| 2020 | -1.77 |
FAQ
- What is Tango Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Tango Therapeutics, Inc.?
- What is TNGX EV/EBITDA year-to-date change?
- What is Tango Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Tango Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of TNGX is -9.53
What is the all-time high EV/EBITDA for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high EV/EBITDA is 1.58
What is TNGX EV/EBITDA year-to-date change?
Tango Therapeutics, Inc. EV/EBITDA has changed by -8.75 (-1121.79%) since the beginning of the year
What is Tango Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, TNGX EV/EBITDA has changed by -8.97 (-1601.79%)